Investment Q&A

Q: Can you please comment on the latest news release, impact - good or bad, and how the companies debt is handled with FX implications after Brexit?

Thanks in advance!

Q: can you do a report on concordia healthcare . thank you.

Q: what is your top 5 stocks with dividend that you think have a lot of torque moving forward thank you .

Q: CXR announced FDA approval for NEW PHOTOFRIN LASER on June,30th,2016 has approved the Co.'s premarket approval application (PMA) for its new Photofrin 630 PDT Laser to attack cancer cells. I consider this approval to be rather significant,however nobody even mention it on BNN.

Q: What has more upside - CXR, SIS or BOS ?

Q: Hello,
I have kept averaging down on this and currently have big losses. Yesterday, a BNN guest said that this is a non investable company.

Should I just sell and bank the loses? It's a registered account so can't even claim losses, keep average down? Hold my nose for a year or so? Can it go belly up?

Thanks
Marios

Q: What are your thoughts on this company? What do you believe is the price target for this stock?

Q: Do you know if all of Concordia's debt is in British Pounds from the Aimco acquisition? Do you know if the former owners payout happening this year is in British Pounds as well?

Thank you, Shane

Q: Now that some of the initial panic in the markets after the Brexit vote seems to be settling down, what are your current thoughts regarding the potential sale of the company and probable timing?

Q: Hi 5i,

Say you were to sell shares of CXR.TO in a Canadian Dollar account at a loss and then purchase shares of CXRX.US in a US dollar account. Am I right assume you cannot claim the loss for tax-loss selling because you are ultimately buying the same security?

Thanks, Shane

Q: I know you have mentioned that CXR has gone down with Valeant and that the fundamentals are still good. Yes they have debt but a lot of free cash flow to pay it down. But this stock just continues to fall, to ridiculously low prices. There was also another Seeking Alpha report posted today bashing the company.At what level would you say investors should get out of it, if it continues on this path?

Q: Could you please comment on the G&M article mentioning CXR:
http://www.theglobeandmail.com/globe-investor/investment-ideas/the-top-20-canadian-companies-exposed-to-the-british-pound/article30635313/

Have you seen the CIBC report referenced in it? Could you please share your opinion wrt CXR?

Q: The steep drop in the British pound will have a large impact on Concordia's earnings? Do you know if any of their debt is in the same currency? What would be your assessment of Concordia over the next few quarters?

Q: Because AMCo resides in UK, should that have any bearing on CXR's future performance? Down 10% in early trading today. Or is this a good excuse for the uncommited to bail out of CXR.

Carl

Q: Hi there, I know the two names have very little in common, but which of the two would you own if you had to pick one as being the overall better of the two - which would it be?

Thanks!

Q: I am wondering what you think would have happened to the share price of Concordia had they NOT made the large acquisition of AMCo in September 2015. Do you think CXR would have been better off?

The acquisition of AMCo cost them US$3.5B, and the market liked it initially. They issued 8 million shares at US$65 to help pay for the acquisition. Yet the market cap of CXR is now only US$1.2B, much less than half of what they paid for AMCo, and the share price is now under US$24. Now they put themselves up for sale. Why would they do that?

I know they have been tainted by the problems in the healthcare sector like at VRX, and Hillary’s tweet, but still wasn’t it supposed to be a great acquisition for them, yet the stock has lost almost 75% of its value since then. Yes they have large debt, and that was known when they made the acquisition, and it didn’t seem to matter then. Now everyone cares about it, and the stock is under a short attack.

I want to be a believer in CXR, however, I like to understand what is going on, and at the moment I don’t get it. What lessons can a retail investor learn from this fiasco?

Paul

Q: Will you be covering Concordia Healthcare in the future seeing that it is in the growth portfolio (and there are many questions on it)?

Thanks,
Andrew

Q: First bought a small position when it had dropped to $90 from its alt-time of around $117. Averaged down several months ago to a $53 cost and about a 3.5% position. Am thinking about chasing it at its current price of $29 to lower my cost to $40. Can't understand the downward pressure on this stock. I know it has some debt but also strong earnings. Can't help but think of Teck when it was down below $4 not that long ago and now is over $15. I don't like averaging down but it just seems so mis-priced. Forgetting about the short manipulations, do you you see any faundamental downside risk.

Q: Hello team,
thank you for your all your investments answers and for the ones regarding Concordia Healthcare in particular.
Going forward it seems that unfortunately the sentiment towards Biotech stocks, Brexit, the similarities with Valeant, short attacks and other possible concerns with CXR is simply killing the share price and CXR has become a falling knife...

In addition technically speaking it just broke below 2016 lows... Do you still think its buyable now?

Thx again!

Q: Hi Guys,

Can you speak a bit about the adjustments that CXR has been making to its financials? Is this accounting gimmickry? Is the underlying business sustainable without these adjustments?

My thinking is that these acquisition-related adjustments can't be made forever, so won't reality of low unadjusted earnings one day set in?